{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:06:28Z","timestamp":1781787988376,"version":"3.54.5"},"reference-count":49,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jiangxi Province \u201cDouble Thousand Plan\u201d the first batch of science and technology innovation high-end talent","award":["jxsq2019201027"],"award-info":[{"award-number":["jxsq2019201027"]}]},{"name":"Key Project of Natural Science Foundation of Jiangxi Province","award":["20212ACB206013"],"award-info":[{"award-number":["20212ACB206013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    EIF4A3 (Eukaryotic translation initiation factor 4A3 (EIF4A3) was recently recognized as an oncogene; however, its role in BLCA (bladder cancer) remains unclear. We explored EIF4A3 expression and its prognostic value in BLCA in public datasets, including the TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus). Thereafter, the association between EIF4A3 expression and the infiltration of immune cells and immune-checkpoint expression was determined using TIMER2 (Tumor Immune Estimation Resource 2) tool. Additionally, the impact of EIF4A3 on cellular proliferation and apoptosis events in BLCA cell lines was determined by siRNA technology. In this study, EIF4A3 was found to be significantly upregulated in BLCA, upregulated expression of EIF4A3 was related to poor prognosis, advanced histologic grade, subtype, pathological stage, white race, and poor primary therapy outcome. The immune infiltration analysis revealed that EIF4A3 expression was negatively associated with CD8\n                    <jats:sup>+<\/jats:sup>\n                    and CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells and positively with myeloid-derived suppressor cells, macrophage M2, cancer-associated fibroblasts, and Treg cells. Moreover, EIF4A3 was coexpressed with PD-L1 (programmed cell death 1-ligand 1) and its expression was higher in patients responding to anti-PD-L1 therapy. EIF4A3 knockdown significantly inhibited proliferation and promoted apoptosis in 5,637 and T24 cells. In summary, BLCA patients with elevated EIF4A3 expression had an unfavorable prognosis and immunosuppressive microenvironment, and EIF4A3 may facilitate BLCA progression by promoting cell proliferation and inhibiting apoptosis. Furthermore, our study suggests that EIF4A3 is a potential biomarker and therapeutic target for BLCA.\n                  <\/jats:p>","DOI":"10.7717\/peerj.15309","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T03:58:57Z","timestamp":1683518337000},"page":"e15309","source":"Crossref","is-referenced-by-count":5,"title":["EIF4A3 serves as a prognostic and immunosuppressive microenvironment factor and inhibits cell apoptosis in bladder cancer"],"prefix":"10.7717","volume":"11","author":[{"given":"Bing","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China"},{"name":"Jiangxi Institute of Urology, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China"},{"name":"Jiangxi Institute of Urology, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China"},{"name":"Jiangxi Institute of Urology, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Situ","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China"},{"name":"Jiangxi Institute of Urology, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China"},{"name":"Jiangxi Institute of Urology, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China"},{"name":"Jiangxi Institute of Urology, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"10.7717\/peerj.15309\/ref-1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.trecan.2016.11.009","article-title":"Targeted therapy and immunosuppression in the tumor microenvironment","volume":"3","author":"Allegrezza","year":"2017","journal-title":"Trends Cancer"},{"key":"10.7717\/peerj.15309\/ref-2","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"The New England Journal of Medicine"},{"key":"10.7717\/peerj.15309\/ref-3","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/551S34a","article-title":"Unlocking bladder cancer","volume":"551","author":"Berdik","year":"2017","journal-title":"Nature"},{"key":"10.7717\/peerj.15309\/ref-4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.7717\/peerj.15309\/ref-5","doi-asserted-by":"publisher","first-page":"100412","DOI":"10.1016\/j.ctarc.2021.100412","article-title":"Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN\/PI3K\/AKT pathway to promote non-small cell lung cancer metastasis","volume":"28","author":"Chen","year":"2021","journal-title":"Cancer Treatment and Research Communications"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-6","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","article-title":"Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"Nature Communications"},{"issue":"4","key":"10.7717\/peerj.15309\/ref-7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41419-018-0458-4","article-title":"Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma","volume":"9","author":"Cheng","year":"2018","journal-title":"Cell Death and Disease"},{"key":"10.7717\/peerj.15309\/ref-8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00262-019-02443-4","article-title":"Mechanisms of immune evasion in bladder cancer","volume":"69","author":"Crispen","year":"2020","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.7717\/peerj.15309\/ref-9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ijc.26123","article-title":"Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer","volume":"130","author":"Eruslanov","year":"2012","journal-title":"International Journal of Cancer"},{"key":"10.7717\/peerj.15309\/ref-10","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.7717\/peerj.15309\/ref-11","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1073\/pnas.0400933101","article-title":"A nuclear translation-like factor eIF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay","volume":"101","author":"Ferraiuolo","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.15309\/ref-12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treatment Reviews"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-13","doi-asserted-by":"publisher","first-page":"112855","DOI":"10.1016\/j.yexcr.2021.112855","article-title":"LINC00992 exerts oncogenic activities in prostate cancer via regulation of SOX4","volume":"408","author":"Fu","year":"2021","journal-title":"Experimental Cell Research"},{"key":"10.7717\/peerj.15309\/ref-14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1158\/1078-0432.CCR-15-1135","article-title":"New strategies in bladder cancer: a second coming for immunotherapy","volume":"22","author":"Ghasemzadeh","year":"2016","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12885-019-5353-6","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling","volume":"19","author":"Goulet","year":"2019","journal-title":"BMC Cancer"},{"key":"10.7717\/peerj.15309\/ref-16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/0008-5472.CAN-19-2013","article-title":"IL6\/STAT3 signaling orchestrates premetastatic niche formation and immunosuppressive traits in lung","volume":"80","author":"Jing","year":"2020","journal-title":"Cancer Research"},{"issue":"32","key":"10.7717\/peerj.15309\/ref-17","doi-asserted-by":"publisher","first-page":"eabf7561","DOI":"10.1126\/sciadv.abf7561","article-title":"The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output","volume":"7","author":"Kanellis","year":"2021","journal-title":"Science Advances"},{"key":"10.7717\/peerj.15309\/ref-18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/bju.15209","article-title":"Recurrence- and progression-free survival in intermediate-risk non-muscle-invasive bladder cancer: the impact of conditional evaluation and subclassification","volume":"127","author":"Kohada","year":"2021","journal-title":"BJU International"},{"issue":"10","key":"10.7717\/peerj.15309\/ref-19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41419-019-1896-3","article-title":"LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death and Disease"},{"key":"10.7717\/peerj.15309\/ref-20","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.15309\/ref-21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.urolonc.2013.10.012","article-title":"The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure","volume":"32","author":"Lima","year":"2014","journal-title":"Urologic Oncology"},{"key":"10.7717\/peerj.15309\/ref-22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrm3154","article-title":"From unwinding to clamping\u2014the DEAD box RNA helicase family","volume":"12","author":"Linder","year":"2011","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/cancers13010131","article-title":"Immune checkpoint inhibitors for the treatment of bladder cancer","volume":"13","author":"Lopez-Beltran","year":"2021","journal-title":"Cancers"},{"key":"10.7717\/peerj.15309\/ref-24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13046-021-02138-8","article-title":"Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA","volume":"40","author":"Mao","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.7717\/peerj.15309\/ref-26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.7717\/peerj.15309\/ref-27","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.3390\/ijms18102186","article-title":"Regulatory T cells and tumor-associated macrophages in the tumor microenvironment in non-muscle invasive bladder cancer treated with intravesical bacille calmette-gu\u00e9rin: a long-term follow-up study of a Japanese Cohort","volume":"18","author":"Miyake","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.15309\/ref-28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-2-18","article-title":"PrognoScan: a new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Medical Genomics"},{"key":"10.7717\/peerj.15309\/ref-29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nature02351","article-title":"An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay","volume":"427","author":"Palacios","year":"2004","journal-title":"Nature"},{"key":"10.7717\/peerj.15309\/ref-30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.clgc.2021.04.008","article-title":"Clinical outcomes of platinum-ineligible patients with advanced urothelial carcinoma treated with first-line PD1\/L1 inhibitors","volume":"19","author":"Pond","year":"2021","journal-title":"Clinical Genitourinary Cancer"},{"key":"10.7717\/peerj.15309\/ref-31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1073\/pnas.1612920114","article-title":"COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","volume":"114","author":"Prima","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.15309\/ref-32","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.4049\/jimmunol.167.10.5583","article-title":"Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide","volume":"167","author":"Saio","year":"2001","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.7717\/peerj.15309\/ref-33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/cancers13030551","article-title":"Immune therapy resistance and immune escape of tumors","volume":"13","author":"Seliger","year":"2021","journal-title":"Cancers"},{"key":"10.7717\/peerj.15309\/ref-34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1172\/jci127515","article-title":"Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy","volume":"130","author":"Sharma","year":"2020","journal-title":"Journal of Clinical Investigation"},{"key":"10.7717\/peerj.15309\/ref-35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"7","key":"10.7717\/peerj.15309\/ref-36","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1002\/ctm2.220","article-title":"Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation","volume":"10","author":"Song","year":"2020","journal-title":"Clinical and Translational Medicine"},{"key":"10.7717\/peerj.15309\/ref-37","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.15309\/ref-38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.omtn.2019.10.043","article-title":"LINC00680 and TTN-AS1 stabilized by EIF4A3 promoted malignant biological behaviors of glioblastoma cells","volume":"19","author":"Tang","year":"2020","journal-title":"Molecular Therapy\u2013Nucleic Acids"},{"key":"10.7717\/peerj.15309\/ref-39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.urolonc.2009.07.025","article-title":"Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways","volume":"29","author":"Wallerand","year":"2011","journal-title":"Urologic Oncology"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12935-021-01964-2","article-title":"CircRNA_100290 promotes GC cell proliferation and invasion via the miR-29b-3p\/ITGA11 axis and is regulated by EIF4A3","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell International"},{"key":"10.7717\/peerj.15309\/ref-41","doi-asserted-by":"publisher","first-page":"21674","DOI":"10.18632\/aging.103971","article-title":"Circular RNA circSEMA5A promotes bladder cancer progression by upregulating ENO1 and SEMA5A expression","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-018-0911-0","article-title":"EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis","volume":"17","author":"Wang","year":"2018","journal-title":"Molecular Cancer"},{"key":"10.7717\/peerj.15309\/ref-43","doi-asserted-by":"publisher","first-page":"5739769","DOI":"10.1155\/2021\/5739769","article-title":"circ-SIRT1 promotes colorectal cancer proliferation and EMT by recruiting and binding to eIF4A3","volume":"2021","author":"Wang","year":"2021","journal-title":"Analytical Cellular Pathology"},{"key":"10.7717\/peerj.15309\/ref-44","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1158\/0008-5472.CAN-21-1518","article-title":"Circ0008399 interaction with wtap promotes assembly and activity of the m(6)a methyltransferase complex and promotes cisplatin resistance in bladder cancer","volume":"81","author":"Wei","year":"2021","journal-title":"Cancer Research"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12943-021-01394-8","article-title":"Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-kappaB\/bone remodeling factors signaling","volume":"20","author":"Xu","year":"2021","journal-title":"Molecular Cancer"},{"key":"10.7717\/peerj.15309\/ref-46","doi-asserted-by":"publisher","first-page":"633415","DOI":"10.3389\/fonc.2021.633415","article-title":"Multi-omic analyses of the m(5)C regulator ALYREF reveal its essential roles in hepatocellular carcinoma","volume":"11","author":"Xue","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.7717\/peerj.15309\/ref-47","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/cbin.11361","article-title":"LINC00667 promotes the proliferation, migration, and pathological angiogenesis in non-small cell lung cancer through stabilizing VEGFA by EIF4A3","volume":"44","author":"Yang","year":"2020","journal-title":"Cell Biology International"},{"key":"10.7717\/peerj.15309\/ref-48","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopha.2018.03.071","article-title":"Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and\/or inhibiting NF- \u03baB signaling or PI3K\/AKT\/mTOR pathway","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.7717\/peerj.15309\/ref-49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","article-title":"The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer","volume":"19","author":"Zheng","year":"2020","journal-title":"Molecular Cancer"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/15309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/15309.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/15309.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/15309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T03:59:15Z","timestamp":1683518355000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/15309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":49,"alternative-id":["10.7717\/peerj.15309"],"URL":"https:\/\/doi.org\/10.7717\/peerj.15309","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.7287\/peerj.15309v0.1\/reviews\/3","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.15309v0.1\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.15309v0.1\/reviews\/1","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.15309v0.2\/reviews\/4","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.15309v0.2\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.15309v0.1\/reviews\/4","asserted-by":"object"}]},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"article-number":"e15309"}}